Antibody persistency and trend post-SARS-CoV-2 infection at eight months

Puya Dehgani-Mobaraki, Asiya Kamber Zaidi, Annamaria Porreca, Alessandro Floridi, Emanuela Floridi
doi: https://doi.org/10.1101/2020.11.21.20236117

Article Information

doi 
https://doi.org/10.1101/2020.11.21.20236117
History 
  • November 29, 2020.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Puya Dehgani-Mobaraki, M.D, M.S(ORL)1,*,
  2. Asiya Kamber Zaidi, M.D, M.S (ORL), F.W.A.M.S2,3,
  3. Annamaria Porreca4,
  4. Alessandro Floridi, M.Pharm5 and
  5. Emanuela Floridi, MD5
  1. 1President of Associazione Naso Sano, Umbria region, Italy
  2. 2Senior Registrar, M.G.M Medical College and M.Y Hospital, Indore, M.P, India
  3. 3Member, Associazione Naso Sano, Umbria region, Italy
  4. 4Ph.D student at Department of Economics, University “G.d’Annunzio”, chieti-Pescara, Italy
  5. 5Laboratory of Nuclear Lipid BioPathology, Centro Ricerche Analisi Biochimico Specialistiche, Perugia, Italy
  1. ↵*Corresponding author, Email: dehganipuya{at}gmail.com
Back to top
Posted November 29, 2020.
Download PDF
Data/Code
Email
Antibody persistency and trend post-SARS-CoV-2 infection at eight months
Puya Dehgani-Mobaraki, Asiya Kamber Zaidi, Annamaria Porreca, Alessandro Floridi, Emanuela Floridi
medRxiv 2020.11.21.20236117; doi: https://doi.org/10.1101/2020.11.21.20236117
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area